Links to publications that use this kit:
Lufty et al. Alterations in the level of OFQ/N-IR in rat brain regions by cocaine.Neuropharmacology. 2008 Aug;55(2):198-203. Williams et al. Nociceptin and urotensin-II concentrations in critically ill patients with sepsis.Br J Anaesth. 2008 Jun;100(6):810-4.
Maeshiro et al. Changes in A-type natriuretic peptide and its receptors induced by a neutral endopeptidase inhibitor in a rat model of sepsis.Surg Today. 2008;38(2):130-4.
Ertsey et al. Plasma nociceptin levels are reduced in migraine without aura. Cephalalgia. 2005 Apr;25(4):261-6.
Ertsey et al. Circulating nociceptin levels during the cluster headache period. Cephalalgia. 2004 Apr;24(4):280-3
Horvath et al. Rising plasma nociceptin level during development of HCC: a case report.World J Gastroenterol. 2004 Jan;10(1):152-4.
Szalay et al. Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma.World J Gastroenterol. 2004 Jan;10(1):42-5.
Ko et al. Quantitative analysis of nociceptin in blood of patients with acute and chronic pain.Neuroreport. 2002 Sep 16;13(13):1631-3.
Sun et al. Changes in brain content of nociceptin/orphanin FQ and endomorphin 2 in a rat model of neuropathic painNeurosci Lett. 2001 Sep 21;311(1):13-6.
Armstead. NOC/oFQ contributes to age-dependent impairment of NMDA-induced cerebrovasodilation after brain injuryAm J Physiol Heart Circ Physiol. 2000 Nov;279(5):H2188-95. Kulkarni et al. Superoxide Generation Links Nociceptin/Orphanin FQ (NOC/oFQ) Release to Impaired N-Methyl-D-Aspartate Cerebrovasodilation After Brain InjuryStroke. 2000 Aug;31(8):1990-6.
Yuan et al. Accelerated release and production of orphanin FQ in brain of chronic morphine tolerant rats.Brain Res. 1999 May 1;826(2):330-4.